Literature DB >> 16920963

Exhaustion of type I interferon response following an acute viral infection.

Mohammed Alsharifi1, Matthias Regner, Robert Blanden, Mario Lobigs, Eva Lee, Aulikki Koskinen, Arno Müllbacher.   

Abstract

Viral infections often cause a period of heightened susceptibility to a secondary infection but the cause of this phenomenon is unknown. We found that a primary viral infection in mice rapidly triggers an IFN-I-dependent partial activation state in the majority of B and T lymphocytes, which reverts to a resting phenotype within 5 days. When a secondary infection with an unrelated virus occurred 5 to 9 days after the primary infection, no recurrence of marked activation of lymphocytes was observed. This was not due to an inherent inability of the previously activated cells to undergo renewed partial activation, because they responded when challenged with virus after transfer into "naive" recipients. Instead, the failure to respond optimally resided in the original host's incapacity to mount an IFN-I response to the secondary infection during this time period. Thus, transient immunosuppression through exhaustion of IFN-I production during an acute viral infection creates a time period of enhanced susceptibility to secondary infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920963     DOI: 10.4049/jimmunol.177.5.3235

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  RIG-I and TLR4 responses and adverse outcomes in pediatric influenza-related critical illness.

Authors:  Tanya Novak; Mark W Hall; Douglas R McDonald; Margaret M Newhams; Anushay J Mistry; Angela Panoskaltsis-Mortari; Peter M Mourani; Laura L Loftis; Scott L Weiss; Keiko M Tarquinio; Barry Markovitz; Mary E Hartman; Adam Schwarz; Wolfgang G Junger; Adrienne G Randolph
Journal:  J Allergy Clin Immunol       Date:  2020-02-06       Impact factor: 10.793

2.  Interferon-alpha regulates the dynamic balance between human activated regulatory and effector T cells: implications for antiviral and autoimmune responses.

Authors:  Amit Golding; Antony Rosen; Michelle Petri; Ehtisham Akhter; Felipe Andrade
Journal:  Immunology       Date:  2010-05-06       Impact factor: 7.397

Review 3.  The oncolytic virus, pelareorep, as a novel anticancer agent: a review.

Authors:  Romit Chakrabarty; Hue Tran; Giovanni Selvaggi; Allison Hagerman; Brad Thompson; Matt Coffey
Journal:  Invest New Drugs       Date:  2015-02-19       Impact factor: 3.850

4.  Controlled infection with a therapeutic virus defines the activation kinetics of human natural killer cells in vivo.

Authors:  Y M El-Sherbiny; T D Holmes; L F Wetherill; E V I Black; E B Wilson; S L Phillips; G B Scott; R A Adair; R Dave; K J Scott; R S M Morgan; M Coffey; G J Toogood; A A Melcher; G P Cook
Journal:  Clin Exp Immunol       Date:  2015-04       Impact factor: 4.330

5.  Persistent virus infection inhibits type I interferon production by plasmacytoid dendritic cells to facilitate opportunistic infections.

Authors:  Elina I Zuniga; Li-Ying Liou; Lauren Mack; Marilyn Mendoza; Michael B A Oldstone
Journal:  Cell Host Microbe       Date:  2008-10-16       Impact factor: 21.023

6.  Inhibition of Jak1-dependent signal transduction in airway epithelial cells infected with adenovirus.

Authors:  Lei Shi; Murali Ramaswamy; Lori J Manzel; Dwight C Look
Journal:  Am J Respir Cell Mol Biol       Date:  2007-07-19       Impact factor: 6.914

7.  Acute infection with venezuelan equine encephalitis virus replicon particles catalyzes a systemic antiviral state and protects from lethal virus challenge.

Authors:  Jennifer L Konopka; Joseph M Thompson; Alan C Whitmore; Drue L Webb; Robert E Johnston
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

8.  Gamma-irradiated influenza virus uniquely induces IFN-I mediated lymphocyte activation independent of the TLR7/MyD88 pathway.

Authors:  Yoichi Furuya; Jennifer Chan; En-Chi Wan; Aulikki Koskinen; Kerrilyn R Diener; John D Hayball; Matthias Regner; Arno Müllbacher; Mohammed Alsharifi
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

9.  Lactate dehydrogenase-elevating virus induces systemic lymphocyte activation via TLR7-dependent IFNalpha responses by plasmacytoid dendritic cells.

Authors:  Christoph G Ammann; Ronald J Messer; Karin E Peterson; Kim J Hasenkrug
Journal:  PLoS One       Date:  2009-07-01       Impact factor: 3.240

10.  Gamma-Irradiated Influenza A Virus Provides Adjuvant Activity to a Co-Administered Poorly Immunogenic SFV Vaccine in Mice.

Authors:  Rachelle Babb; Jennifer Chan; Jasmine E Khairat; Yoichi Furuya; Mohammed Alsharifi
Journal:  Front Immunol       Date:  2014-06-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.